evenfolioETF Details
Roundhill Investments·Health·OZEM · Nasdaq
Roundhill GLP-1 & Weight Loss ETF (OZEM)
- Price
- $30.70
- —30 Oct 2026
- Assets
- $57.8M
- Total net assets
- Expense ratio
- 0.59%
- Category 1.00%
- Yield
- 1.33%
- Trailing distributions
- 1Y return
- 10.4%-18.4%
- Category 28.8%
- 3Y CAGR
- —
- Category 21.5%
- 5Y CAGR
- —
- Category 4.1%
Loading NAV history…
Roundhill GLP-1 & Weight Loss ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | -0.3% | -3.3% | -2.1% | -10.1% | +10.4% | — | — | — | +8.7% |
| Health average | 3.6% | 9.9% | 23.0% | 20.4% | 28.8% | 21.5% | 4.1% | 10.8% | 11.6% |
| Difference | -3.9% | -13.2% | -25.1% | -30.6% | -18.4% | — | — | — | -2.9% |
Holdings
The 10 largest positions make up 66.2% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| LLY | Eli Lilly and Co | 12.67% |
| NVO | Novo Nordisk AS ADR | 11.08% |
| PFE | Pfizer Inc | 7.68% |
| 1093.HK | CSPC Pharmaceutical Group Ltd | 6.51% |
| VKTX | Viking Therapeutics Inc | 5.46% |
| KLRA | Kailera Therapeutics Inc | 5.16% |
| 4519.T | Chugai Pharmaceutical Co Ltd | 4.63% |
| 1672.HK | Ascletis Pharma Inc Ordinary Shares | 4.38% |
| AMGN | Amgen Inc | 4.36% |
| 128940.KQ | Hanmi Pharm Co Ltd | 4.32% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- 18.6
- P/B
- 3.2
- P/S
- 4.5
- P/CF
- 14.1
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks99.9%
- Other0.2%
ETF details
- Issuer
- Roundhill Investments
- Category
- Equity · Health
- Ticker
- OZEM
- Exchange
- Nasdaq
- Inception
- 20 May 2024 (2.4 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.59% (category 1.00%)
- Holdings turnover
- 66% (category 51%)
- Distribution yield
- 1.33%
- Beta, 3 years
- 0.00
- Total net assets
- $57.8M
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- HRTS · Tema Heart & Health ETFTema ETFs · $53.7M · ER 0.75%
- FMED · Fidelity Disruptive Medicine ETFFidelity Investments · $52.3M · ER 0.50%
- BBC · Virtus Biotech Clinical Trials ETFVirtus · $43.8M · ER 0.65%5Y 0.0%
- MEDI · Harbor Health Care ETFHarbor Capital Advisors Inc · $41.7M · ER 0.80%
- HELX · Franklin Genomic Advancements ETFFranklin Templeton, Inc · $33.4M · ER 0.50%5Y -3.1%
- TMED · T. Rowe Price Health Care ETFT. Rowe Price · $33M · ER 0.44%